Cost Evaluation of Current Pulmonary MTB Diagnosis Process in a Hospital in Abu Dhabi and Proposal to Implement the World Health Organization MTB Clinical Pathway
Aim:Mycobacterium tuberculosis (MTB) is a leading cause of death worldwide. The World Health Organization (WHO) recommends X-pert MTB/RIF or X-pert Ultra as the initial test for pulmonary MTB diagnosis. While several studies have explored the cost-effectiveness of this technology, none have specific...
Main Authors: | Ward Ghaleb, Yamama Aljishi, Sanjay Ayathan, Ayesha Almemari |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2023-06-01
|
Series: | Eurasian Journal of Emergency Medicine |
Subjects: | |
Online Access: |
http://eajem.com/archives/archive-detail/article-preview/cost-evaluation-of-current-pulmonary-mtb-diagnosis/60681
|
Similar Items
-
An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF
by: Yeliz Tanriverdi Cayci, et al. -
Evaluation of Xpert MTB/RIF Assay, MTB Culture and Line Probe Assay for the Detection of MDR Tuberculosis in AFB Smear Negative Specimens
by: Chandri Lama, et al.
Published: (2022-10-01) -
The diagnostic performance of endobronchial ultrasound with Xpert MTB/RIF Ultra in smear-negative pulmonary tuberculosis
by: Lan Yao, et al.
Published: (2023-02-01) -
Implementation of the Xpert MTB/RIF assay for tuberculosis in Mongolia: a qualitative exploration of barriers and enablers
by: Nicole L. Rendell, et al.
Published: (2017-07-01) -
Xpert MTB/RIF Ultra Assay Using Stool: an Effective Solution for Bacilli Identification from Adult Pulmonary Tuberculosis Suspects without Expectorated Sputum
by: Xia Yu, et al.
Published: (2023-08-01)